Open Terminal →

Analyses / MOH

MOH Molina Healthcare Inc As of Nov 19, 2026
$206.56

Shares fell 6.6% on the day to $206.56 but remain about 70% up their 52-week range. Revenue growth is solid, while margins are thin and EPS is declining.

Setup: Post-drop reassessment Confidence: medium Horizon: 1-3 months Risk: high Category: Large cap managed care (~$10.8B market cap, Health Care)
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals MOH's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Revenue grew 12.4% (5Y: 18.5%). Forward P/E 24.5x and P/S 0.25x. Insiders logged 47 purchase transactions versus 16 sales (147,484 shares bought vs 51,412 sold). Price remains well above the $121.06 52-week low. If the day's decline proves sentiment-driven, a recovery toward the $221 prior close is possible.

▼ Bear Case

Net margin is only 1.04% and operating margin 1.72%, so small cost shifts can move earnings. TTM EPS growth is -12.7%. Trailing P/E is unavailable. The stock fell 6.6% to $206.56 on a day with a $203.41 low, and the payload does not explain the cause. Policy headlines on Medicare and Medicaid billing are in the news flow.

Valuation

mixed — score 45/100

Forward P/E and EV/EBITDA are moderate, P/S is low, but thin margins and negative EPS growth limit the read. No sector benchmark in payload.

Technical Levels

Support · $203.41 (Day low) · $196.00 (Entry zone floor (derived)) · $121.06 (52-week low)

Resistance · $220.66 (Day high) · $221.21 (Prior close) · $244.89 (52-week high)

RSI: Not available in payload

Financial Health

Score 55/100. Liquidity ratios are adequate and beta is low. Leverage and coverage cannot be assessed from the payload.

Catalysts

Next earnings report (date not in payload)Not in payloadhigh
Medicare/Medicaid billing and marketplace enrollment policyOngoing (per Benzinga headline)medium
Cause of the -6.6% day move (unconfirmed)Recent sessionmedium

Risk Flags

Net margin 1.04% and operating margin 1.72%: thin buffer against cost or reimbursement changes.
EPS growth -12.73% TTM and -4.47% 5Y, while revenue grew 12.42%.
Trailing P/E null in payload. Forward P/E 24.46x is the only earnings multiple provided.
Day move -6.6% with no cause in payload. The 'What Sent Molina Stock Higher?' headline conflicts with the price direction.
Null fields: ROE, ROIC, debt/equity, interest coverage, FCF/share, RSI, dividend. Fundamentals, balance sheet, cash flow, and sentiment blocks are empty.
Medicare/Medicaid policy headline targets billing and marketplace enrollment practices. Impact not quantified in payload.

See MOH's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock MOH free →

Recent News

More Analyses

MOH FAQ

Is MOH a buy right now?

Molina Healthcare Inc's current read is a Post-drop reassessment setup with medium confidence over a 1-3 months horizon. Valuation: mixed. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is MOH overvalued?

mixed (valuation score 45/100). Forward P/E and EV/EBITDA are moderate, P/S is low, but thin margins and negative EPS growth limit the read. No sector benchmark in payload.

What are the risks of buying MOH?

Net margin is only 1.04% and operating margin 1.72%, so small cost shifts can move earnings. TTM EPS growth is -12.7%. Trailing P/E is unavailable. The stock fell 6.6% to $206.56 on a day with a $203.41 low, and the payload does not explain the cause. Policy headlines on Medicare and Medicaid billing are in the news flow.